DCGI permits ‘Sputnik Light’ to conduct Phase III trials in India

The Drug Controller General of India has approved the single-dose COVID vaccine Sputnik Light to conduct phase 3 trials on the Indian population

The Drug Controller General of India has granted permission to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population. This is to check whether the vaccine gives a similar immune response in trials same as in the Russian population. Sputnik Light is a single dose COVID19 vaccine of the Russian vaccine Sputnik. Its phase-3 trials have so far been conducted in Russia, the UAE, and Ghana.

According to a study published in the medical journal The Lancet, Sputnik Light showed 78.6 to 83.7 percent efficacy against Covid-19, 28 days after administration, significantly higher than most two-shot vaccines. 

Sputnik V confirmed 83.1% efficacy against the Delta variant of Covid — higher than many other vaccines. The vaccine showed a six times reduction of infection risk. Sputnik V is also 94.4% effective against hospitalizations, with 18 times reduction in such risk. Sputnik V vaccine has been registered in 69 countries globally with a total population of over 3.7 billion people. Sputnik V is considered to be one of the safest and most effective vaccines against coronavirus.

The Russian Direct Investment Fund (RDIF) last year united with Dr. Reddy's Laboratories to conduct the phase III trials of the Sputnik V vaccine in India. In April, Sputnik V received an emergency use authorization in India. Reddy's administered the first dose of the vaccine in Hyderabad under a limited pilot on May 14.

Tags : #Spotlight #SputnikV #SputnikLight #COVID19 #DCGI #SingledoseCOVIDvaccine #RDIF #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024